FiftyBidsGovernment contracts and grants, sent to your inbox.

Back to search

Forecast

Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)

The National Mesothelioma Virtual Bank (NMVB) was established in 2006 to serve as a resource for malignant mesothelioma research. This funding opportunity will advance biomedical research for malignant mesothelioma by adding more biospecimens together with demographic data and clinical data.

FromCenters for Disease Control and Prevention - ERA
Who can applystate governments, counties, cities and townships, special districts (water, fire, parks, etc.), school districts, public colleges and universities and 10 more types
Eligibility notesApplicant institution must have an established registry and tissue bank with the capability of functioning as a national virtual registry and tissue bank for mesothelioma, one in which participating institutions will make available their independent stores of…
How much$750K to $1.1 million per award; about 1 award; $5.5 million total
DeadlineMon, Nov 2, 2026 (estimated) (10 days left)
CategoryHealth
TypeCooperative agreement
Opportunity #RFA-OH-27-048
Assistance listing93.262
PostedWed, Jul 22, 2026

Heads-up: Forecast: not open yet. Dates and amounts are the agency's estimates.

Open the official posting

From the notice

The National Mesothelioma Virtual Bank (NMVB) was established in 2006 to serve as a resource for malignant mesothelioma research. This funding opportunity will advance biomedical research for malignant mesothelioma by adding more biospecimens together with demographic data and clinical data. Examples of biospecimens include fresh frozen tumor and control tissues, paraffin embedded tissues, blood, DNA, RNA, and protein samples from mesothelioma patients. Demographic data includes age, sex, race, and occupational history. Clinical data includes stage, treatment, and survival information. The virtual registry and tissue bank also serve as a virtual repository and offer a library of biospecimens and data that investigators can use and share, including genomic, transcriptomic, and proteomic data. The NMVB can: Help identify early signs of disease. Support the development of biomarkers that show disease stage and prognosis. Help develop new or improved treatment options. The goal is to continue to expand the NMVB and improve its ability to be a resource for both biomedical researchers and the clinical science community focused on malignant mesothelioma research.

We may have shortened this. The official posting is the record. We are not affiliated with the agency that published it.